FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295138766> ?p ?o ?g. }

• W4295138766 endingPage "1506.e2" @default.
• W4295138766 startingPage "1498" @default.
• W4295138766 abstract "Chronic spontaneous urticaria (CSU) is inadequately controlled in many patients and greatly affects quality of life. Remibrutinib, a highly selective, oral, novel covalent Bruton tyrosine kinase inhibitor, might be effective in CSU.This first-in-patient trial aimed to evaluate the efficacy and safety of remibrutinib in CSU treatment and characterize the dose-response.This randomized, double-blind, placebo-controlled, phase 2b dose-finding trial evaluated remibrutinib (12 weeks) in patients inadequately controlled with second-generation H1-antihistamines, with at least moderately active CSU, with or without prior anti-IgE treatment (NCT03926611). Patients received remibrutinib 10 mg once daily, 35 mg once daily, 100 mg once daily, 10 mg twice daily, 25 mg twice daily, 100 mg twice daily, or placebo (1:1:1:1:1:1:1 ratio). The main end points were weekly Urticaria Activity Score change from baseline at week 4 and safety.Overall, 311 patients were randomized. Reduced symptom score was observed for all remibrutinib doses from week 1 until week 12, with weekly Urticaria Activity Score change from baseline at week 4: -19.1 (10 mg once daily), -19.1 (35 mg once daily), -14.7 (100 mg once daily), -16.0 (10 mg twice daily), -20.0 (25 mg twice daily), -18.1 (100 mg twice daily), and -5.4 for placebo (nominal P < .0001 for all doses vs placebo). Most adverse events were mild or moderate, with no dose-dependent pattern.Remibrutinib was highly effective in the treatment of CSU over the entire dose range, with a rapid onset of action and a favorable safety profile." @default.
• W4295138766 created "2022-09-11" @default.
• W4295138766 creator A5003305956 @default.
• W4295138766 creator A5049910869 @default.
• W4295138766 creator A5054433237 @default.
• W4295138766 creator A5062276217 @default.
• W4295138766 creator A5062536923 @default.
• W4295138766 creator A5064160667 @default.
• W4295138766 creator A5078829922 @default.
• W4295138766 creator A5081068514 @default.
• W4295138766 creator A5087439946 @default.
• W4295138766 creator A5089494697 @default.
• W4295138766 creator A5091156366 @default.
• W4295138766 date "2022-12-01" @default.
• W4295138766 modified "2023-10-15" @default.
• W4295138766 title "Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria" @default.
• W4295138766 cites W1748713341 @default.
• W4295138766 cites W1846442784 @default.
• W4295138766 cites W1975940271 @default.
• W4295138766 cites W2001622051 @default.
• W4295138766 cites W2007417599 @default.
• W4295138766 cites W2010769998 @default.
• W4295138766 cites W2022025463 @default.
• W4295138766 cites W2025003624 @default.
• W4295138766 cites W2051265496 @default.
• W4295138766 cites W2056866975 @default.
• W4295138766 cites W2101858940 @default.
• W4295138766 cites W2124562077 @default.
• W4295138766 cites W2163083601 @default.
• W4295138766 cites W2165948492 @default.
• W4295138766 cites W2166422945 @default.
• W4295138766 cites W2243756594 @default.
• W4295138766 cites W2345476533 @default.
• W4295138766 cites W2400798468 @default.
• W4295138766 cites W2534434153 @default.
• W4295138766 cites W2619731065 @default.
• W4295138766 cites W2746717744 @default.
• W4295138766 cites W2765477066 @default.
• W4295138766 cites W2791441078 @default.
• W4295138766 cites W2804563776 @default.
• W4295138766 cites W2970721464 @default.
• W4295138766 cites W2978592627 @default.
• W4295138766 cites W2985341438 @default.
• W4295138766 cites W3006726493 @default.
• W4295138766 cites W3009751573 @default.
• W4295138766 cites W3013137634 @default.
• W4295138766 cites W3025403097 @default.
• W4295138766 cites W3086675157 @default.
• W4295138766 cites W3087522660 @default.
• W4295138766 cites W3121976021 @default.
• W4295138766 cites W3135275383 @default.
• W4295138766 cites W3141219512 @default.
• W4295138766 cites W3198455975 @default.
• W4295138766 cites W3200862524 @default.
• W4295138766 cites W3212896089 @default.
• W4295138766 cites W4213337080 @default.
• W4295138766 doi "https://doi.org/10.1016/j.jaci.2022.08.027" @default.
• W4295138766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36096203" @default.
• W4295138766 hasPublicationYear "2022" @default.
• W4295138766 type Work @default.
• W4295138766 citedByCount "23" @default.
• W4295138766 countsByYear W42951387662022 @default.
• W4295138766 countsByYear W42951387662023 @default.
• W4295138766 crossrefType "journal-article" @default.
• W4295138766 hasAuthorship W4295138766A5003305956 @default.
• W4295138766 hasAuthorship W4295138766A5049910869 @default.
• W4295138766 hasAuthorship W4295138766A5054433237 @default.
• W4295138766 hasAuthorship W4295138766A5062276217 @default.
• W4295138766 hasAuthorship W4295138766A5062536923 @default.
• W4295138766 hasAuthorship W4295138766A5064160667 @default.
• W4295138766 hasAuthorship W4295138766A5078829922 @default.
• W4295138766 hasAuthorship W4295138766A5081068514 @default.
• W4295138766 hasAuthorship W4295138766A5087439946 @default.
• W4295138766 hasAuthorship W4295138766A5089494697 @default.
• W4295138766 hasAuthorship W4295138766A5091156366 @default.
• W4295138766 hasBestOaLocation W42951387661 @default.
• W4295138766 hasConcept C126322002 @default.
• W4295138766 hasConcept C142724271 @default.
• W4295138766 hasConcept C168563851 @default.
• W4295138766 hasConcept C197934379 @default.
• W4295138766 hasConcept C204787440 @default.
• W4295138766 hasConcept C27081682 @default.
• W4295138766 hasConcept C42219234 @default.
• W4295138766 hasConcept C71924100 @default.
• W4295138766 hasConcept C90924648 @default.
• W4295138766 hasConceptScore W4295138766C126322002 @default.
• W4295138766 hasConceptScore W4295138766C142724271 @default.
• W4295138766 hasConceptScore W4295138766C168563851 @default.
• W4295138766 hasConceptScore W4295138766C197934379 @default.
• W4295138766 hasConceptScore W4295138766C204787440 @default.
• W4295138766 hasConceptScore W4295138766C27081682 @default.
• W4295138766 hasConceptScore W4295138766C42219234 @default.
• W4295138766 hasConceptScore W4295138766C71924100 @default.
• W4295138766 hasConceptScore W4295138766C90924648 @default.
• W4295138766 hasIssue "6" @default.
• W4295138766 hasLocation W42951387661 @default.
• W4295138766 hasLocation W42951387662 @default.
• W4295138766 hasLocation W42951387663 @default.

• next